PSA analysis in three Norwegian counties in 1999;PSA-analyser i tre norske fylker i 1999

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 21, 2000, Pages 2539-2541

  Skovlund, Eva ^a   Fosså, Sophie D ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; BLOOD; FOLLOW UP; HUMAN; IMMUNOLOGY; MALE; MASS SCREENING; MIDDLE AGED; NORWAY; PROSTATE TUMOR; QUESTIONNAIRE;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NORWAY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; TUMOR MARKERS, BIOLOGICAL;

EID: 0034633137     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Labrie F, Candas B, Dupont A, Cusan L, Gomez J-L, Suburu R et al. Screening decreases prostate cancer death: first analysis of the 1988 Quebec Prospective Randomized Controlled Trial. Prostate 1999; 38: 83-91.
2. Schröder FH, Bangma CH. The European randomized study of screening for prostate cancer (ERSPC). Br J Urol 1997; 79: 68-71.
3. Fosså SD, Eri LM. Norske legers rutiner for opportunistisk screening for prostatacancer. Tidsskr Nor Lægeforen 1999; 119: 3572-6.
4. Senter for medisinsk metodeutvikling. Screening for prostatakreft. SMM-Rapport nr. 3, 1999. Oslo: SINTEF Unimed, 1999.